Status:
TERMINATED
Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change
Lead Sponsor:
3M
Collaborating Sponsors:
Sharp HealthCare
Conditions:
Surgical Site Infection
Eligibility:
All Genders
2+ years
Brief Summary
Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fra...
Detailed Description
Infection rate study.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will be enrolled in the study.
Exclusion
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
333 Patients enrolled
Trial Details
Trial ID
NCT01148030
Start Date
June 1 2010
End Date
July 1 2012
Last Update
March 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sharp Memorial Hospital
San Diego, California, United States, 92123